06:34 AM EDT, 09/23/2026 (MT Newswires) -- The UK and Singapore launched negotiations for a new mutual recognition agreement on pharmaceutical good manufacturing practice aimed at reducing regulatory duplication and cutting trade costs, according to a Wednesday release. The agreement will allow the UK's Medicines and Healthcare products Regulatory Agency and Singapore's Health Sciences Authority to rely on each other's laboratory inspection results, making medicines trade between the two markets more efficient by reducing administrative barriers while maintaining regulatory requirements.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.